Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract
Intravacc has been awarded a contract with base and options that may total US$14.6 million…
October 5, 2022 - 3 minutes
Sexually Transmitted Diseases
A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections
This week we're traveling to Bergen, a beautiful coastal city in Norway surrounded by seven…
July 7, 2017 - 2 minutes
Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer
The RAIDs consortium made its closing event last week. After 4.5 years of studies, it…
June 14, 2017 - 5 minutes
€4M Grant for a Cancer Vaccine that could Bench its Competitors
Hookipa just secured a huge grant from the Austrian government. The plan is to develop…
October 18, 2016 - 2 minutes
Transgene teams up with big Players against HPV Head and Neck Cancer
Transgene is partnering with Merck and Pfizer to develop a combined therapy for head and…
October 12, 2016 - 3 minutes
After its drop earlier this year, Genticel goes back up the slope
Genticel has announced that not one but two milestones have been achieved in the development…
June 17, 2016 - 3 minutes
Genticel is vaccinating against Cervical Cancer AFTER Infection
Estonia, our previous destination by the Baltic Sea, was a delightful and a full of…
June 10, 2016 - 2 minutes
Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%
Genticel (France) is a clinical biotech developing a cervical cancer immunotherapy against the Human papillomavirus. However, their 24-month phase…
January 28, 2016 - 3 minutes
The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach
The Dutch Oncology VC Specialist Aglaia has invested €3.4M in the Swiss Start-Up Inthera Bioscience…
December 17, 2015 - 3 minutes
Genticel aims to prevent Cancer caused by the Human Papillomavirus
Genticel is a step closer to prevent cancer caused by the human papillomavirus (HPV). The…
June 2, 2015 - 2 minutes
